Sclerostin as a biomarker of cardiovascular risk in women with systemic lupus erythematosus

Cardiovascular disease is one of the main causes of death in patients with systemic lupus erythematosus (SLE). On the other hand, sclerostin is a reliable and early biomarker of vascular calcification. This study aimed to estimate the association between sclerostin and two markers of cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-de los Ríos, Carlos, Medina-Casado, Marta, Díaz-Chamorro, Antonio, Sierras-Jiménez, María, Lardelli-Claret, Pablo, Cáliz-Cáliz, Rafael, Sabio, José Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749620/
https://www.ncbi.nlm.nih.gov/pubmed/36517533
http://dx.doi.org/10.1038/s41598-022-25651-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9749620/
https://www.ncbi.nlm.nih.gov/pubmed/36517533
http://dx.doi.org/10.1038/s41598-022-25651-y

Ejemplares similares